Jinxin H. Wang
Jiangsu Key Laboratory Of Drug Design And Optimization
Nanjing, 210009, China
Nanjing, 210009, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
Novel Resveratrol Derivatives as Dual PDE4 Inhibitors and Free Radical Scavengers: Rational Design, Synthesis, and Biological Evaluation.
Journal: Antioxidants (Basel, Switzerland)
Published: May 12, 2026
Discovery of Peripherally Restricted Indazole-Based Phosphodiesterase 4B Inhibitors Targeting the C-terminal Regulatory Helix for Treating Acute Lung Injury.
Journal: Journal of medicinal chemistry
Published: March 03, 2026
Targeting S1P signaling for drug development.
Journal: Drug discovery today
Published: December 14, 2025
Assessment of Tanshinone IIA Derivatives for Cardioprotection in Myocardial Ischemic Injury.
Journal: Planta medica
Published: March 24, 2025
Design, synthesis and biological evaluation of pyrrolopyrimidine urea derivatives as novel KRASG12C inhibitors for the treatment of cancer.
Journal: European journal of medicinal chemistry
Published: December 21, 2024
Discovery of a Novel ASM Direct Inhibitor with a 1,5-Diphenyl-pyrazole Scaffold and Its Antidepressant Mechanism of Action.
Journal: Journal of medicinal chemistry
Published: June 18, 2024
Discovery of a novel class of reversible monoacylglycerol lipase inhibitors for potential treatment of depression.
Journal: European journal of medicinal chemistry
Published: January 10, 2024
Hybrids of selective COX-2 inhibitors and active derivatives of edaravone as COX-2 selective NSAIDs with free radical scavenging activity: Design, synthesis and biological activities.
Journal: European journal of medicinal chemistry
Published: November 29, 2023
Multiple medicinal chemistry strategies of targeting KRAS: State-of-the art and future directions.
Journal: Bioorganic chemistry
Published: September 28, 2023
Design and synthesis of a novel class of PDE4 inhibitors with antioxidant properties as bifunctional agents for the potential treatment of COPD.
Journal: European journal of medicinal chemistry
Published: February 25, 2023
Discovery of Novel N-Hydroxy-1,2,4-oxadiazole-5-formamides as ASM Direct Inhibitors for the Treatment of Atherosclerosis.
Journal: Journal of medicinal chemistry
Published: February 14, 2023
Sappanone A: A natural PDE4 inhibitor with dual anti-inflammatory and antioxidant activities from the heartwood of Caesalpinia sappan L.
Journal: Journal of ethnopharmacology
Published: September 22, 2022
Last Updated: 09/26/2026